Artificial intelligence augmenting medical management

OP36: A colonic gene expression signature predicts nonresponse to anti-inflammatory therapies in Inflammatory Bowel Disease

Robot and surgeon: How will a partnership work?

OP37: Efficacy and safety of ustekinumab as maintenance therapy in Ulcerative Colitis: Week 44 results from UNIFI

OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with Moderately to Severely Active Ulcerative Colitis

Big data: Potential for transforming IBD research and care